Cellectis S.A. American (CLLS) Total Assets by Year
Cellectis S.A. American closed fiscal year 2025 with $324.7M in total assets, $248.8M in total liabilities and $75.9M in shareholder equity. This represents a decrease of 15.3% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Cellectis S.A. American has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CLLS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $324.7M-15.3% | $383.5M+14.7% | $334.3M+28.0% | $261.2M-31.6% | $382.1M-18.6% | $469.5M+0.4% | $467.5M-6.7% | $500.8M+50.5% | $332.9M+0.4% | $331.4M-10.7% | $371.3M+122.2% | $167.1M |
| Total Liabilities | $248.8M-1.5% | $252.5M+1.2% | $249.6M+84.5% | $135.3M-7.1% | $145.6M-9.4% | $160.6M+43.4% | $112.0M+121.5% | $50.6M+3.4% | $48.9M-16.3% | $58.4M-32.1% | $86.1M-9.2% | $94.8M |
| Total Equity | $75.9M-42.1% | $131.0M+54.7% | $84.7M-32.8% | $125.9M-46.7% | $236.5M-23.4% | $308.8M-13.1% | $355.5M-21.1% | $450.3M+58.6% | $284.0M+4.0% | $273.0M-4.3% | $285.3M+294.7% | $72.3M |
CLLS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q2'256-K/A | Q4'2420-F | Q2'246-K/A | Q4'2310-K | Q3'2310-K | Q2'2310-Q | Q4'2210-K | Q2'2210-Q | Q4'2110-K | Q2'2110-Q | Q4'2010-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $324.7M-15.3% | $354.0M-13.1% | $383.5M+14.7% | $407.1M+78.8% | $334.3M+28.0% | $209.7M | $227.7M-29.0% | $261.2M-31.6% | $320.9M-29.9% | $382.1M-18.6% | $457.6M-3.2% | $469.5M+0.4% |
| Total Liabilities | $248.8M-1.5% | $256.9M-0.7% | $252.5M+1.2% | $258.5M+97.2% | $249.6M+84.5% | $133.6M | $131.1M-6.6% | $135.3M-7.1% | $140.4M-9.6% | $145.6M-9.4% | $155.2M+21.6% | $160.6M+43.4% |
| Total Equity | $75.9M-42.1% | $97.1M-34.7% | $131.0M+54.7% | $148.6M+53.9% | $84.7M-32.8% | $76.1M | $96.6M-46.5% | $125.9M-46.7% | $180.5M-40.3% | $236.5M-23.4% | $302.3M-12.4% | $308.8M-13.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Cellectis S.A. American financials
Frequently Asked Questions
What was Cellectis S.A. American's total assets in fiscal year 2025?
Cellectis S.A. American closed fiscal year 2025 with $324.7M in total assets, $248.8M in total liabilities and $75.9M in shareholder equity.
How fast is Cellectis S.A. American's total assets growing?
Cellectis S.A. American (CLLS) total assets fell by 15.3% year over year, from $383.5M to $324.7M in fiscal year 2025.
How has Cellectis S.A. American's total assets changed over the years?
Across the 12 fiscal years this page covers, Cellectis S.A. American (CLLS) total assets went from $167.1M in fiscal year 2014 to $324.7M in fiscal year 2025.
What was Cellectis S.A. American's total assets in the most recent quarter?
Cellectis S.A. American (CLLS) reported $324.7M in total assets in Q4 2025. This represents a decrease of 15.3% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Cellectis S.A. American (CLLS) reported on that line in every period on record.